High-throughput screening for the assessment of time-dependent inhibitions of new drug candidates on recombinant CYP2D6 and CYP3A4 using a single concentration method

By Yamamoto T.   Suzuki A.   Kohno Y.  

Xenobiotica, Vol. 34, Iss. 1, 2004-01 ,pp. : 87-101

Informa Healthcare

Access to resources Recommend Favorite

Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes

By Miyazawa M.   Gyoubu K.  

Xenobiotica, Vol. 37, Iss. 2, 2007-02 ,pp. : 194-204

Informa Healthcare

Access to resources Recommend Favorite

A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes

By Rahikainen Tuomas   Häkkinen Merja R.   Finel Moshe   Pasanen Markku   Juvonen Risto O.  

Xenobiotica, Vol. 43, Iss. 10, 2013-10 ,pp. : 853-861

Informa Healthcare

Access to resources Recommend Favorite

Identification of cytochrome P450 enzymes involved in the metabolism of 3',4'-methylenedioxy- a -pyrrolidinopropiophenone (MDPPP), a designer drug, in human liver microsomes

By Springer D   Staack R. F   Paul L. D   Kraemer T   Maurer H. H  

Xenobiotica, Vol. 35, Iss. 3, 2005-03 ,pp. : 227-237

Informa Healthcare

Access to resources Recommend Favorite